glp 1 resistance One in 10 people may have to GLP-1 diabetes drugs Mechanism by which excessive circulating

The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

In summary, tirzepatide was noninferior and superior to semaglutide with respect to the reduction of HbA1c from baseline to 40 weeks (54, 71)

My hunger is quieter and I'm losing weight without obsessing

Spread it out

It adds bulk to stool and stimulates the stretch receptors in your colon that trigger peristalsis

Our observations about the efficacy of GLP-1 RAs in enhancing survival and reducing cardiovascular events are concordance with evidence from several cardiovascular outcome trials (CVOTs) conducted in general population with T2DM, as well as a recent cohort study focused on solid organ transplant recipients [16,17,18,19, 23]